Table 5 Gene expression analysis of the HMC3 (ATCC®CRL-3304) cells
From: The human microglial HMC3 cell line: where do we stand? A systematic literature review
Gene | Control (mean threshold cycle, Ct) | II (Fold variation relative to control) |
|---|---|---|
Pro-inflammatory genes | ||
IL-6 | 27.97 ± 0.17 (n = 12) | 43.75 ± 2.59 (n = 11) |
TNFα | 32.50 ± 0.20 (n = 12) | 5.37 ± 0.45 (n = 11) |
IL1β | 29.02 ± 0.10 (n = 12) | 4.71 ± 0.32 (n = 12) |
COX2 | 33.00 ± 0.50 (n = 9) | 2.51 ± 0.46 (n = 9) |
NOS2 | No Ct (n = 9) | No Ct (n = 9) |
Anti-inflammatory genes | ||
TGFβ | 28.50 ± 0.16 (n = 12) | 1.02 ± 0.06 (n = 12) |
ARG1 | 29.51 ± 0.10 (n = 10) | 1.07 ± 0.07 (n = 11) |